The Research and Development team at DayTwo focuses on innovating and enhancing the company's unique solutions for metabolic disease management. By leveraging gut microbiome sequencing and artificial intelligence, the team collaborates on projects that optimize personalized treatment plans and improve patient outcomes. Their efforts encompass data analysis, microbiome research, and the integration of virtual care technologies to drive sustainable health improvements.